Delivery Order SPE2DB20D2014-SPE2DB25FC81U
- Not listed
- The Defense Logistics Agency awarded a $3,689.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Entresto 24 mg-26 mg tablets (60-count supply) on July 18, 2025, with an ultimate completion date of July 21, 2025. This non-competitive delivery order was placed against AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order will be fulfilled at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Entresto 49 mg-51 mg tablets (180-count supply) with a ceiling value of $51,539.65. This is a firm fixed-price delivery order with an ultimate completion date of July 21, 2025, and represents a competitively awarded contract with no set-aside designation. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $17,962.22 on August 4, 2025, for the supply of Entresto 24 mg-26 mg tablets (180-count). This competitively awarded, firm fixed-price delivery order is non-set-aside and will be performed at the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 5, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $68,784.07 delivery order to AmerisourceBergen Drug Corp for the supply of Entresto 49 mg-51 mg tablets (180-count units) on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a direct fulfillment under the company's broader pharmaceutical supply arrangements. The place of performance is AmerisourceBergen's corporate office location...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Entresto 49 mg-51 mg tablets (180-count units) with a ceiling value of $17,820.70. This firm fixed-price delivery order, with an ultimate completion date of August 13, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The contract was...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Entresto 97 mg-103 mg tablets (180-count units) under a firm fixed-price contract with a ceiling value of $5,359.73. This non-competitive delivery order is set to be completed by August 25, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of the company's role as a critical...
- The Defense Logistics Agency awarded a $1,295.96 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Entresto 49 mg-51 mg tablets (180-count). This firm fixed-price delivery order is non-competitive and will be completed by August 11, 2025, with performance originating from AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $5,013.67 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Entresto 49 mg-51 mg tablets (180-count). This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 25, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Entresto 49 mg-51 mg tablets (180-count) valued at $3,510.76. This firm fixed-price delivery order represents a non-competitive, non-set-aside award and is scheduled for completion by July 29, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor for this pharmaceutical supply transaction, which will be fulfilled from...
- The Defense Logistics Agency awarded a $2,440.48 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Entresto 49 mg-51 mg tablets (180-count units). This contract, which is not set-aside and was competitively awarded, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC81UDelivery Order
The Defense Logistics Agency awarded a $6,279.78 delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Entresto 49 mg-51 mg tablets (180-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of August 25, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen leverages its comprehensive IDC vehicle to support military and veteran healthcare systems with an extensive portfolio of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains. The underlying IDC serves as a global pharmaceutical support mechanism enabling AmerisourceBergen to supply Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This specific delivery order for Entresto—a cardiovascular medication—represents one of numerous pharmaceutical deliveries the company fulfills through its established relationship with the Defense Logistics Agency's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.3k | 8/22/25 |